Fibrillin is a glycoprotein, which is essential for the formation of elastic fibers found in connective tissue.[1] Fibrillin-1 is a major component of the microfibrils that form a sheath surrounding the amorphous elastin. It is believed that the microfibrils are composed of end-to-end polymers of fibrillin. To date, 3 forms of fibrillin have been described. The fibrillin-1 protein was isolated by Sakai in 1986,[2] and mutations in the gene have been linked to the Marfan syndrome. At present more than 100 different mutations have been described. Fibrillin-2 was isolated in 1994 by Zhang[3] and is thought to play a role in early elastogenesis. Mutations in the fibrillin-2 gene have been linked to Beal's Syndrome. More recently, fibrillin-3 was described and is believed to be located mainly in the brain.[4] Along with in the brain, fibrillin 1 has been localized in the gonads and ovaries of field mice.
Protein
connective tissue protein fibrillin-1.
A defective fibrillin protein can cause Marfan syndrome, a genetic disorder that affects the body's connective tissue. This can lead to a range of symptoms, including tall stature, long limbs, joint hypermobility, and heart problems such as aortic dilation and dissection.
The gene associated with Marfan syndrome is located on chromosome 15. It is called the FBN1 gene, which provides instructions for making a protein called fibrillin-1. Mutations in this gene can lead to the characteristic features of Marfan syndrome.
It is caused by a mutation in the gene for fibrillin-1 on chromosone 15. A variable disorder of the connective tissue that effects many organ systems including the skeleton.eyes,heart,lungs and blood vessels.
It affects the body's production of fibrillin, which is a protein that is an important part of connective tissue.
Yes. Marfan syndrome is a congenital disorder affecting the formation of fibrillin. In Marfan syndrome, the abnormal fibrillin is responsible for many of the findings of the disease. Hyperextensibility/hyperelasticity of joints is one of the hallmark signs. Pectus excavatum is another. People with Marfan syndrome are typically very tall and thin, with very long fingers and toes (arachnodactyly). The fibrillin defect also affects the blood vessels, especially the large arteries, such as the aorta. Disordered fibrillin production causes these arteries to be weaker than normal, predisposing patients with Marfan syndrome to aortic dissections and rupture. This the major cause of death for patients with Marfan syndrome.
marfan syndrome is genetic disorder of connective tissue of the body. it cause a mutation of the gene that produces the protein fibrillin.
Marfan syndrome is typically caused by mutations in the FBN1 gene, which provides instructions for making a protein called fibrillin-1. These mutations can result in the production of an abnormal fibrillin-1 protein, leading to the characteristic features of Marfan syndrome such as tall stature, long limbs, and cardiovascular issues.
No, Marfan syndrome is not a chromosomal abnormality. It is a genetic disorder caused by a mutation in the fibrillin-1 (FBN1) gene, which affects the body's connective tissue. This gene is located on chromosome 15.
Yes. Marfan syndrome is caused by a defect (or mutation) in the gene that tells the body how to make fibrillin-1.
Mutations of the fibrillin gene (FBNI) are unique to each family affected by Marfan, which makes rapid genetic diagnosis impossible, given present technology.